Tilak Mandadi - 01 Apr 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP, Chief Technology Officer
Signature: /s/ Tilak Mandadi
Issuer symbol: CVS
Transactions as of: 01 Apr 2023
Net transactions value: +$7,170,618
Form type: 4
Filing time: 04 Apr 2023, 16:34:11 UTC
Previous filing: 02 Sep 2022
Next filing: 01 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CVS	Common Stock (RSU)						99,847	01 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$7,170,618	+96,496		$74.31	96,496	01 Apr 2023	Common Stock	96,496	$74.31	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023.
F2	Option becomes exercisable in four equal annual installments, commencing 4/1/2024.